ADCIRCA
- Product NDC
- 66302-467
- 11-digit product format
- 663020467
- Labeler code
- 66302
- Product ID
- 66302-467_76c30323-0981-499c-b552-1a43f01c89c8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tadalafil
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- United Therapeutics Corporation
- Application
- NDA022332
- Marketing category
- NDA
- Marketing start
- 2009-05-22
- Substance
- TADALAFIL
- Active strength
- 20 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ADCIRCA
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TADALAFIL | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 742SXX0ICT |
| Rxcui | 849866, 2123194 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 66302-467-60 | ADCIRCA | 60 in 1 BOTTLE | TABLET | 60 | | 34 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 66302-467 | ADCIRCA (TADALAFIL) TABLET [UNITED THERAPEUTICS CORPORATION] | 33 | Current NDC, Legacy NDC, 1 package rows | 20241215_ff61b237-be8e-461b-8114-78c52a8ad0ae.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 66302-467-60 | 66302046760 | 60 TABLET in 1 BOTTLE (66302-467-60) | 60 tablet | 2009-08-03 | 0000-00-00 | No | No | Current |
| 66302-467-61 | 66302046761 | 14 TABLET in 1 BOTTLE (66302-467-61) | 14 tablet | 2011-05-11 | 0000-00-00 | Yes | No | Current |